Nancy E. Jones

2.2k total citations
21 papers, 1.0k citations indexed

About

Nancy E. Jones is a scholar working on Cognitive Neuroscience, Clinical Psychology and Genetics. According to data from OpenAlex, Nancy E. Jones has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cognitive Neuroscience, 10 papers in Clinical Psychology and 9 papers in Genetics. Recurrent topics in Nancy E. Jones's work include Autism Spectrum Disorder Research (14 papers), Genetics and Neurodevelopmental Disorders (9 papers) and Family and Disability Support Research (9 papers). Nancy E. Jones is often cited by papers focused on Autism Spectrum Disorder Research (14 papers), Genetics and Neurodevelopmental Disorders (9 papers) and Family and Disability Support Research (9 papers). Nancy E. Jones collaborates with scholars based in United States, United Kingdom and Canada. Nancy E. Jones's co-authors include Joseph P. Horrigan, Daniel L. Coury, Alan K. Percy, Daniel G. Glaze, Jeffrey L. Neul, Katherine Sullivan, Alycia Halladay, Lawrence David Scahill, Géraldine Dawson and Paul H. Patterson and has published in prestigious journals such as Neurology, PEDIATRICS and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Nancy E. Jones

21 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy E. Jones United States 14 728 421 388 296 164 21 1.0k
Erik J. Mulder Netherlands 15 738 1.0× 322 0.8× 354 0.9× 306 1.0× 135 0.8× 24 1.1k
Maria Valicenti-McDermott United States 10 587 0.8× 432 1.0× 160 0.4× 349 1.2× 54 0.3× 19 820
A M Small United States 12 437 0.6× 229 0.5× 129 0.3× 469 1.6× 64 0.4× 17 696
G. Bartolucci Canada 10 738 1.0× 295 0.7× 277 0.7× 248 0.8× 37 0.2× 15 876
Carol Stott United Kingdom 13 504 0.7× 225 0.5× 251 0.6× 134 0.5× 79 0.5× 22 804
Tom Humphries Canada 19 388 0.5× 198 0.5× 182 0.5× 583 2.0× 59 0.4× 32 1.1k
Nicola Gillan United Kingdom 15 892 1.2× 408 1.0× 323 0.8× 317 1.1× 101 0.6× 17 1.0k
John Wray Australia 17 835 1.1× 446 1.1× 228 0.6× 438 1.5× 115 0.7× 41 1.2k
Audrey Mars United States 8 608 0.8× 249 0.6× 208 0.5× 276 0.9× 62 0.4× 11 818
Páll Magnússon Iceland 12 540 0.7× 347 0.8× 319 0.8× 406 1.4× 90 0.5× 17 948

Countries citing papers authored by Nancy E. Jones

Since Specialization
Citations

This map shows the geographic impact of Nancy E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Jones more than expected).

Fields of papers citing papers by Nancy E. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Jones. The network helps show where Nancy E. Jones may publish in the future.

Co-authorship network of co-authors of Nancy E. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. Jones. A scholar is included among the top collaborators of Nancy E. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. Jones. Nancy E. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Melissa, Larry Glass, Daniel G. Glaze, et al.. (2024). Development of trofinetide for the treatment of Rett syndrome: from bench to bedside. Frontiers in Pharmacology. 14. 1341746–1341746. 8 indexed citations
2.
Neul, Jeffrey L., Alan K. Percy, Tim A. Benke, et al.. (2022). Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemporary Clinical Trials. 114. 106704–106704. 43 indexed citations
3.
Glaze, Daniel G., Jeffrey L. Neul, Walter E. Kaufmann, et al.. (2019). Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. Neurology. 92(16). e1912–e1925. 112 indexed citations
4.
Glaze, Daniel G., Jeffrey L. Neul, Alan K. Percy, et al.. (2017). A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome. Pediatric Neurology. 76. 37–46. 76 indexed citations
5.
Horrigan, Joseph P., et al.. (2017). Population pharmacokinetics of NNZ-2566 in healthy subjects. European Journal of Pharmaceutical Sciences. 109. S98–S107. 13 indexed citations
6.
Lane, Jane B., Amber Salter, Nancy E. Jones, et al.. (2017). Assessment of Caregiver Inventory for Rett Syndrome. Journal of Autism and Developmental Disorders. 47(4). 1102–1112. 14 indexed citations
7.
Percy, Alan K., Daniel G. Glaze, Jeffrey L. Neul, et al.. (2017). 1.49 Trofinetide, A Novel IGF-1 Related Treatment for Neurodevelopmental Disorders, Demonstrates Efficacy for Children and Adolescents With Rett Syndrome. Journal of the American Academy of Child & Adolescent Psychiatry. 56(10). S168–S169. 1 indexed citations
8.
Neul, Jeffrey L., Daniel G. Glaze, Alan K. Percy, et al.. (2015). Improving Treatment Trial Outcomes for Rett Syndrome. Journal of Child Neurology. 30(13). 1743–1748. 54 indexed citations
9.
Anagnostou, Evdokia, Nancy E. Jones, Marisela Huerta, et al.. (2014). Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorder. Autism. 19(5). 622–636. 145 indexed citations
10.
Schumann, John H., et al.. (2014). The Neurobiology of Learning. 5 indexed citations
11.
Schumann, John H., et al.. (2014). The Neurobiology of Aptitude. 21–36. 4 indexed citations
12.
Lecavalier, Luc, Jeffrey J. Wood, Alycia Halladay, et al.. (2013). Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 44(5). 1128–1143. 127 indexed citations
13.
Scahill, Lawrence David, Michael G. Aman, Luc Lecavalier, et al.. (2013). Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism. 19(1). 38–52. 66 indexed citations
14.
Lajonchere, Clara, Nancy E. Jones, Daniel L. Coury, & James M. Perrin. (2012). Leadership in Health Care, Research, and Quality Improvement for Children and Adolescents With Autism Spectrum Disorders: Autism Treatment Network and Autism Intervention Research Network on Physical Health. PEDIATRICS. 130(Supplement_2). S62–S68. 37 indexed citations
15.
Perrin, James M., Daniel L. Coury, Nancy E. Jones, & Clara Lajonchere. (2012). The Autism Treatment Network and Autism Intervention Research Network on Physical Health: Future Directions. PEDIATRICS. 130(Supplement_2). S198–S201. 5 indexed citations
16.
Jones, Nancy E.. (2011). The use of cohesive markers in narratives by children with Williams syndrome. Applied Psycholinguistics. 34(2). 277–299. 1 indexed citations
17.
Coury, Daniel L., et al.. (2009). Healthcare for children with autism: the Autism Treatment Network. Current Opinion in Pediatrics. 21(6). 828–832. 41 indexed citations
18.
Schumann, John H., et al.. (2004). The Neurobiology of Learning: Perspectives From Second Language Acquisition. 60 indexed citations
19.
Ramee, Stephen R., Donald S. Baim, Sanjeev Sharma, et al.. (2001). Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial. American Heart Journal. 142(4). 648–656. 15 indexed citations
20.
Jones, Nancy E.. (1981). Termination of Skilled Nursing Facility Medicaid Provider Agreements: Procedural Due Process Requirements. American Journal of Law & Medicine. 6(4). 451–493. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik J. Mulder Breakdown of academic impact, for papers by Maria Valicenti-McDermott Breakdown of academic impact, for papers by A M Small Breakdown of academic impact, for papers by G. Bartolucci Breakdown of academic impact, for papers by Carol Stott Breakdown of academic impact, for papers by Tom Humphries Breakdown of academic impact, for papers by Nicola Gillan Breakdown of academic impact, for papers by John Wray Breakdown of academic impact, for papers by Audrey Mars Breakdown of academic impact, for papers by Páll Magnússon
Rankless by CCL
2026